|
USP22 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.60160000209453E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.858400E-03 |
| Normal-vs-Stage2 |
5.80280000050948E-07 |
| Normal-vs-Stage3 |
4.35029789969121E-11 |
| Normal-vs-Stage4 |
5.4815999994684E-07 |
| Stage1-vs-Stage2 |
1.977290E-03 |
| Stage1-vs-Stage3 |
1.34070000001874E-06 |
| Stage1-vs-Stage4 |
4.227500E-04 |
| Stage2-vs-Stage3 |
8.633400E-01 |
| Stage2-vs-Stage4 |
9.545000E-01 |
| Stage3-vs-Stage4 |
9.230600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1710999664748E-09 |
| Normal-vs-AfricanAmerican |
1.692160E-01 |
| Normal-vs-Asian |
6.785200E-01 |
| Caucasian-vs-AfricanAmerican |
7.609700E-02 |
| Caucasian-vs-Asian |
4.403900E-02 |
| AfricanAmerican-vs-Asian |
3.640400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77030001768941E-09 |
| Normal-vs-Female |
7.403800E-04 |
| Male-vs-Female |
2.123900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.166100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.36899999999496E-05 |
| Normal-vs-Age(61-80Yrs) |
1.71489999978292E-08 |
| Normal-vs-Age(81-100Yrs) |
1.163390E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.871000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.084400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.179800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.328400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.425700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.009400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.562000E-01 |
| Normal-vs-Grade 2 |
1.362050E-03 |
| Normal-vs-Grade 3 |
1.57599999717206E-09 |
| Normal-vs-Grade 4 |
2.99460001240703E-09 |
| Grade 1-vs-Grade 2 |
7.734300E-02 |
| Grade 1-vs-Grade 3 |
2.621800E-03 |
| Grade 1-vs-Grade 4 |
6.427000E-04 |
| Grade 2-vs-Grade 3 |
3.062900E-03 |
| Grade 2-vs-Grade 4 |
3.372200E-04 |
| Grade 3-vs-Grade 4 |
1.028230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.153800E-04 |
| Normal-vs-ccB subtype |
8.82789999989697E-07 |
| ccA subtype-vs-ccB subtype |
3.742200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64050000028837E-07 |
| Normal-vs-N1 |
7.008400E-02 |
| N0-vs-N1 |
9.102000E-01 |
|
|
